Lipid‐lowering effect of Pinus sp. sawdust and Pycnoporus sanguineus mycelium in streptozotocin‐induced diabetic rats

The purpose of this study was to investigate the effect of diet supplementations on biochemical, hematological, and redox metabolism parameters in streptozotocin‐induced diabetic rats. Healthy male Wistar rats and streptozotocin‐induced diabetic rats were provided diets supplemented with 20% of Pinus sp. sawdust or Pycnoporus sanguineus mycelium for 4 weeks. Diabetic rats treated with both Pinus sp. sawdust‐ and P. sanguineus mycelium‐supplemented diets presented a significant decrease in non‐HDL cholesterol of 38.43% and 33.53% and triglycerides of 70.03% and 69.81%, respectively, compared to diabetic control. As far as we know, this is the first report of a significant decrease in serum lipids attributed to these supplementations. Even though with the alterations in hematological and redox metabolism parameters related to these diet treatments, our data suggest that Pinus sp. sawdust and Pycnoporus sanguineus mycelium could be a useful a diet supplement to control diabetic dyslipidemia in animals. Practical applications Pinus sp. sawdust is a residue from the wood industry that can be reused as a substrate to cultivate Pycnoporus sanguineus mycelium. Both species have specific and rich natural compounds. The results of the present study surprisingly showed that diets supplemented with the isolated substrate (Pinus sp. sawdust) and Pycnoporus sanguineus mycelium significantly decrease non‐HDL cholesterol and triglycerides in induced diabetic animal model. These new natural approaches can be interesting to develop a nutraceutical to treat dyslipidemia. Pinus sp. sawdust is a substrate to produce Pycnoporus sanguineus mycelium and both are rich in fibre and phenolic compounds. Streptozotocin‐induced diabetic rats were treated with Pinus sp. sawdust and Pycnoporus sanguineus mycelium‐supplement diets. Both, Pinus sp. sawdust and Pycnoporus sanguineus mycelium promote lipid‐lowering effect.